HIV therapy in 2003
- 1 April 2003
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17, S4-S11
- https://doi.org/10.1097/00002030-200304001-00002
Abstract
HIV therapy has well-established and substantial clinical benefits. Awareness of these benefits has brought many infected persons into care. Many more infected persons would be treated were it not for the frequent side effects associated with antiretroviral drugs. All antiretroviral agents can cause both short-term and long-term toxicities. This is a particularly vexing problem as current data does not allow accurate predictions of treatment toxicities and, in many cases, side effects are only partially reversible. Moreover, therapy is frequently associated with the selection of drug-resistant viral isolates and incomplete viral suppression. This is commonly caused by inadequate medication adherence and leads to increasingly severe virologic failure. The present review will address both the striking advantages of HIV therapy as well as the ongoing challenges in its application.Keywords
This publication has 31 references indexed in Scilit:
- Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV DiseaseAnnals of Internal Medicine, 2001
- Survival After AIDS Diagnosis in Adolescents and Adults During the Treatment Era, United States, 1984-1997Published by American Medical Association (AMA) ,2001
- Diagnosis of Primary HIV-1 InfectionAnnals of Internal Medicine, 2001
- Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral TherapyAnnals of Internal Medicine, 2000
- Risk for Preventable Opportunistic Infections in Persons with AIDS after Antiretroviral Therapy Increases CD4+T Lymphocyte Counts above Prophylaxis ThresholdsThe Journal of Infectious Diseases, 2000
- 3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and LamivudineAnnals of Internal Medicine, 2000
- AIDS across Europe, 1994–98: the EuroSIDA studyThe Lancet, 2000
- Antiretroviral Therapy in AdultsJAMA, 2000
- Immune Reconstitution in the First Year of Potent Antiretroviral Therapy and Its Relationship to Virologic ResponseThe Journal of Infectious Diseases, 2000
- Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USAPublished by American Medical Association (AMA) ,1996